Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of a peer-mediated intervention on the language and socialization experiences and skills of preschool children<sup>☆</sup>.

Early childhood research quarterly·2026

Same author

Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

Drug metabolism and disposition: the biological fate of chemicals·2026

Same author

Enhancing primary care detection and referral of nightmare disorder: a quality improvement initiative : Journal name: Sleep and Breathing.

Sleep & breathing = Schlaf & Atmung·2026

Same author

Formononetin: a promising therapeutic agent targeting the gut-lung axis in acute lung injury.

Frontiers in pharmacology·2026

Same author

Targeted delivery and ROS-responsive release of celastrol by a macrophage membrane biomimetic liposome alleviates acute kidney injury.

Nanoscale·2026

Same author

Examination of the Utility of Ultrasound in Prenatal Diagnosis and Perinatal Outcomes for 13 Instances of Mirror Syndrome.

Journal of visualized experiments : JoVE·2026

Search research articles

Related Experiment Video

Updated: Jun 16, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

A Full-Spectrum Generative Lead Discovery (FSGLD) Pipeline via DRUG-GAN: A Multiscale Method for

Junmei Wang^1,2, Beihong Ji², Matthew Brock²

¹Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310018, Zhejiang, China.

Research Square

|June 5, 2025

Summary

This summary is machine-generated.

Full-Spectrum Generative Lead Discovery (FSGLD) uses deep learning to efficiently identify drug leads. This AI-driven approach accelerates the discovery of novel compounds targeting specific receptors like CB2.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Related Experiment Videos

Last Updated: Jun 16, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Area of Science:

Computational chemistry
Drug discovery
Artificial intelligence in medicine

Background:

Traditional drug lead identification is often costly and time-consuming.
The integration of computational methods with experimental validation is crucial for efficient drug discovery.
Deep learning offers potential for accelerating the design of novel chemical entities.

Purpose of the Study:

To introduce the Full-Spectrum Generative Lead Discovery (FSGLD) pipeline for efficient drug lead identification.
To demonstrate the capability of FSGLD in designing novel, target-specific compounds.
To optimize computational protocols for reduced calculation time and cost.

Main Methods:

Utilized deep learning with generative adversarial networks (DRUG-GAN) for *de novo* compound design.
Integrated generative modeling with molecular docking, molecular dynamics, MM-PBSA, and thermodynamic integration (TI).
Employed experimental validation for *in vitro* assessment of designed compounds.

Main Results:

FSGLD successfully generated novel, drug-like, and target-specific compounds, outperforming traditional computer-aided drug design (CADD) methods.
Achieved significant reduction (80-90%) in TI calculation time while maintaining accuracy.
Identified novel chemical compounds specifically targeting the CB2 receptor.

Conclusions:

FSGLD provides an efficient and cost-effective pipeline for identifying novel drug leads.
The integration of generative AI with *in silico* and *in vitro* methods accelerates the drug discovery process.
FSGLD offers substantial benefits for both academic research and the pharmaceutical industry.